Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 June 2023 | Story Danelle Fisher | Photo Supplied
South Campus SRC uses conversations to break gender bias
Students listening attentively to speakers at the Break the Bias Conversations held at Legae Residence on the South Campus.

On 24 May 2023, the University of the Free State (UFS) South Campus Student Representative Council (SRC) held the Break the Bias Conversations dialogue at Legae Residence on the South Campus to talk about biases faced by the LGBTQI+ community. 

Established in 2022, the initiative aims to educate students on the different issues faced by students on a daily basis. "This dialogue aimed to educate students on a wide range of topics related to mental health, safety, and racial disparities experienced by our students," states Gonste Choane, Senior Officer, Kovsie Support. 

The SRC has created a safe space for students to address biases towards the LGBTQI+ community, with topics on awareness surrounding the community, including discrimination, sexual health, stereotypes and stigmatisation, and becoming more aware of conscious and unconscious biases and being willing to question ourselves and others. "There was a need to start dialogues/engagements among South Campus students regarding issues they encounter on a regular basis," added Choane. 

The dialogue was attended by South Campus students, the Gender Equity and Anti-Discrimination Office, and associations and NGOs centred around the LGBTQI+ community. "It's important for the university community to be aware of these dialogues in order to provide the necessary support mechanisms that will enhance the academic success of all students," said Choane.  

Guest speakers from diverse backgrounds were invited to share their experiences with the students. 

“The initiative has successfully managed to open the door for open discussions among students regarding issues they face on a regular basis. The initiative's goal now being growth in collaboration with more campuses. "This dialogue aims to collaborate with other campuses in the future," said Choane. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept